S&P 500   3,093.84 (+0.06%)
DOW   27,725.41 (+0.12%)
QQQ   201.53 (0.00%)
CGC   18.68 (-2.96%)
BABA   182.38 (-2.45%)
GE   11.31 (-1.05%)
T   39.17 (+0.00%)
F   8.90 (-1.55%)
ACB   3.53 (-1.12%)
BAC   32.79 (-0.94%)
DIS   138.42 (-0.12%)
S&P 500   3,093.84 (+0.06%)
DOW   27,725.41 (+0.12%)
QQQ   201.53 (0.00%)
CGC   18.68 (-2.96%)
BABA   182.38 (-2.45%)
GE   11.31 (-1.05%)
T   39.17 (+0.00%)
F   8.90 (-1.55%)
ACB   3.53 (-1.12%)
BAC   32.79 (-0.94%)
DIS   138.42 (-0.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BIO-TECHNEQiagenNeurocrine BiosciencesModernabluebird bio
SymbolNASDAQ:TECHNYSE:QGENNASDAQ:NBIXNASDAQ:MRNANASDAQ:BLUE
Price Information
Current Price$203.94$32.39$110.71$18.40$77.95
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$206.80$33.83$106.47$27.56$142.66
% Upside from Price Target1.40% upside4.46% upside-3.83% downside49.76% upside83.02% upside
Trade Information
Market Cap$7.74 billion$7.13 billion$10.20 billion$5.83 billion$4.31 billion
Beta1.220.831.2N/A2.17
Average Volume168,6621,292,147803,5371,528,637603,609
Sales & Book Value
Annual Revenue$714.01 million$1.50 billion$451.24 million$135.07 million$54.58 million
Price / Sales10.894.8622.5945.4079.02
Cashflow$5.99 per share$2.52 per share$0.50 per shareN/AN/A
Price / Cash34.0412.87220.96N/AN/A
Book Value$30.78 per share$11.69 per share$5.30 per share$4.65 per share$34.47 per share
Price / Book6.632.7720.893.962.26
Profitability
Net Income$96.07 million$190.38 million$21.11 million$-384,730,000.00$-555,630,000.00
EPS$3.80$1.34$0.22($4.95)($10.68)
Trailing P/E Ratio53.6724.17503.23N/AN/A
Forward P/E Ratio39.2921.8933.05N/AN/A
P/E Growth$4.33$2.36$5.61N/AN/A
Net Margins12.68%-1.68%3.12%-652.57%-1,326.56%
Return on Equity (ROE)13.36%12.24%5.67%-38.25%-42.29%
Return on Assets (ROA)8.14%5.83%2.63%-30.23%-34.48%
Dividend
Annual Payout$1.28N/AN/AN/AN/A
Dividend Yield0.63%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio33.68%N/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.47%0.68%0.83%N/A0.12%
Current Ratio4.44%2.45%7.08%7.40%6.22%
Quick Ratio3.41%2.18%6.99%7.40%6.22%
Ownership Information
Institutional Ownership Percentage91.53%61.95%95.08%43.12%N/A
Insider Ownership Percentage4.20%9.00%4.30%34.50%3.00%
Miscellaneous
Employees2,2504,952585760764
Shares Outstanding38.11 million225.51 million92.09 million333.25 million55.33 million
Next Earnings Date2/4/2020 (Estimated)2/3/2020 (Estimated)2/4/2020 (Estimated)3/11/2020 (Estimated)2/20/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 BIO-TECHNEQiagenNeurocrine BiosciencesModernabluebird bio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel